Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xufei Huang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood Reviews|March 25, 2017
Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?Chunlan Zhang, Xufei Huang, Jian Li
American Journal of Translational Research|November 21, 2025
Efficacy and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma patientsXufei Huang, Yirong Zhu, Xuemei Wen, et al.
Leukemia & Lymphoma|November 9, 2018
Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasoneHongbo Yang, Hao Zhao, Xufei Huang, et al.
Peerj|August 23, 2016
Bone lesions in Chinese POEMS syndrome patients: imaging characteristics and clinical implicationsFengdan Wang, Xufei Huang, Yan Zhang, et al.
Scientific Reports|October 13, 2025
Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter studyXufei Huang, Chunlan Zhang, Kejia Liu, et al.
Frontiers in Oncology|March 18, 2026
A real-world 10-year follow-up analysis of survival and safety of CD20-targeted therapy in patients with Waldenstrom macroglobulinemiaHengming Zhang, Xufei Huang, Yirong Zhu, et al.
Orphanet Journal of Rare Diseases|June 19, 2016
Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasoneHongbo Yang, Xufei Huang, Qianqian Cai, et al.
Frontiers in Endocrinology|November 16, 2020
Endocrine Evaluation in POEMS Syndrome: A Cohort StudyHongbo Yang, Hao Zhao, Xuemin Gao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[The usage of Mayo staging system in Chinese patients with primary light chain amyloidosis]Xufei Huang, Jun Feng, Congli Zhang, et al.
Future Oncology (London, England)|February 26, 2025
Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocolYunxiang Zhang, Min Wu, Zhen Jin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood Reviews|March 25, 2017
Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?Chunlan Zhang, Xufei Huang, Jian Li
American Journal of Translational Research|November 21, 2025
Efficacy and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma patientsXufei Huang, Yirong Zhu, Xuemei Wen, et al.
Leukemia & Lymphoma|November 9, 2018
Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasoneHongbo Yang, Hao Zhao, Xufei Huang, et al.
Peerj|August 23, 2016
Bone lesions in Chinese POEMS syndrome patients: imaging characteristics and clinical implicationsFengdan Wang, Xufei Huang, Yan Zhang, et al.
Scientific Reports|October 13, 2025
Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter studyXufei Huang, Chunlan Zhang, Kejia Liu, et al.
Frontiers in Oncology|March 18, 2026
A real-world 10-year follow-up analysis of survival and safety of CD20-targeted therapy in patients with Waldenstrom macroglobulinemiaHengming Zhang, Xufei Huang, Yirong Zhu, et al.
Orphanet Journal of Rare Diseases|June 19, 2016
Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasoneHongbo Yang, Xufei Huang, Qianqian Cai, et al.
Frontiers in Endocrinology|November 16, 2020
Endocrine Evaluation in POEMS Syndrome: A Cohort StudyHongbo Yang, Hao Zhao, Xuemin Gao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[The usage of Mayo staging system in Chinese patients with primary light chain amyloidosis]Xufei Huang, Jun Feng, Congli Zhang, et al.
Future Oncology (London, England)|February 26, 2025
Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocolYunxiang Zhang, Min Wu, Zhen Jin, et al.
Pageof 1